GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.83 $1.41 Thursday, 18th Apr 2024 VXRT stock ended at $0.84. This is 2.75% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 8.23% from a day low at $0.83 to a day high of $0.90.
90 days $0.715 $1.54
52 weeks $0.530 $1.59

Historical Vaxart prices

Date Open High Low Close Volume
2024-04-18 $0.86 $0.90 $0.83 $0.84 807 895
2024-04-17 $0.89 $0.91 $0.86 $0.87 1 060 277
2024-04-16 $0.91 $0.92 $0.86 $0.89 1 279 010
2024-04-15 $0.93 $0.95 $0.87 $0.91 1 622 731
2024-04-12 $1.00 $1.04 $0.90 $0.91 2 457 082
2024-04-11 $1.01 $1.04 $0.96 $1.04 1 560 928
2024-04-10 $1.04 $1.04 $1.00 $1.01 1 170 192
2024-04-09 $1.10 $1.10 $1.00 $1.04 1 430 657
2024-04-08 $1.06 $1.11 $1.01 $1.08 1 516 067
2024-04-05 $1.10 $1.16 $1.01 $1.08 2 007 282
2024-04-04 $1.22 $1.30 $1.07 $1.13 4 645 708
2024-04-03 $1.25 $1.25 $1.18 $1.23 1 169 999
2024-04-02 $1.26 $1.28 $1.22 $1.24 1 268 936
2024-04-01 $1.33 $1.34 $1.25 $1.30 1 541 792
2024-03-28 $1.33 $1.41 $1.28 $1.30 2 778 684
2024-03-27 $1.22 $1.31 $1.21 $1.29 1 604 967
2024-03-26 $1.24 $1.25 $1.21 $1.22 798 353
2024-03-25 $1.28 $1.28 $1.22 $1.23 2 282 675
2024-03-22 $1.25 $1.28 $1.18 $1.26 1 799 216
2024-03-21 $1.24 $1.27 $1.22 $1.23 1 181 840
2024-03-20 $1.19 $1.25 $1.17 $1.24 1 475 010
2024-03-19 $1.16 $1.29 $1.14 $1.16 2 910 397
2024-03-18 $1.11 $1.16 $1.08 $1.16 1 150 131
2024-03-15 $1.11 $1.16 $1.03 $1.08 2 035 406
2024-03-14 $1.11 $1.13 $1.09 $1.10 1 171 955
Click to get the best stock tips daily for free!

About Vaxart

Vaxart Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the t... VXRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT